{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:36:21Z","timestamp":1791963381071,"version":"4.3.4"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/jcp.0b013e3181fae248","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T05:06:35Z","timestamp":1288328795000},"page":"661-666","source":"Crossref","is-referenced-by-count":42,"title":["Effect of FTO, SH2B1, LEP, and LEPR Polymorphisms on Weight Gain Associated With Antipsychotic Treatment"],"prefix":"10.1097","volume":"30","author":[{"given":"Rocio","family":"Perez-Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Amado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Berja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Garcia-Unzueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obdulia Mart\u00ednez","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jes\u00fas","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Vazquez-Barquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2007.10.022","article-title":"Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naive population.","volume":"99","author":"Perez-Iglesias","year":"2008","journal-title":"Schizophr Res"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajmg.b.20169","article-title":"Weight gain associated with the 759C\/T polymorphism of the 5HT2C receptor and olanzapine.","volume":"134","author":"Ellingrod","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/JCP.0b013e31819302c3","article-title":"Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.","volume":"29","author":"Gunes","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajmg.b.30115","article-title":"Clozapine-induced weight gain associated with the 5HT2C receptor 759C\/T polymorphism.","volume":"133","author":"Miller","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.160.4.677","article-title":"Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.","volume":"160","author":"Reynolds","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00041444-200409000-00003","article-title":"Lack of association between the 759C\/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.","volume":"14","author":"Theisen","year":"2004","journal-title":"Psychiatr Genet"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(02)11706-5","article-title":"759C\/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.","volume":"360","author":"Basile","year":"2002","journal-title":"Lancet"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2004.12.037","article-title":"The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.","volume":"379","author":"Muller","year":"2005","journal-title":"Neurosci Lett"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hup.903","article-title":"An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects.","volume":"23","author":"Saiz","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1192\/bjp.bp.107.041723","article-title":"Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia.","volume":"192","author":"Yevtushenko","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"suppl 23","key":"R11-3-20210128","first-page":"45","article-title":"Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.","volume":"62","author":"Basile","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R12-3-20210128","first-page":"235","article-title":"No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0893-133X(96)00090-5","article-title":"Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.","volume":"15","author":"Rietschel","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ajmg.b.30311","article-title":"Weight gain associated with the alpha2a-adrenergic receptor 1,291 C\/G polymorphism and olanzapine treatment.","volume":"141","author":"Park","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4088\/JCP.v69n0909","article-title":"Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.","volume":"69","author":"Ujike","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.1141634","article-title":"A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.","volume":"316","author":"Frayling","year":"2007","journal-title":"Science"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1467-789X.2008.00481.x","article-title":"FTO: the first gene contributing to common forms of human obesity.","volume":"9","author":"Loos","year":"2008","journal-title":"Obes Rev"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/ng2048","article-title":"Variation in FTO contributes to childhood obesity and severe adult obesity.","volume":"39","author":"Dina","year":"2007","journal-title":"Nat Genet"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10654-006-9045-6","article-title":"Effect of genetic variation in the leptin gene promoter and the leptin receptor gene on obesity risk in a population-based case-control study in Spain.","volume":"21","author":"Portoles","year":"2006","journal-title":"Eur J Epidemiol"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0003480000008277","article-title":"Association of the G-2548A polymorphism in the 5 region of the LEP gene with overweight.","volume":"64","author":"Mammes","year":"2000","journal-title":"Ann Hum Genet"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s004390100468","article-title":"A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women.","volume":"108","author":"Quinton","year":"2001","journal-title":"Hum Genet"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/422699","article-title":"Common variants in the 5 region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study.","volume":"75","author":"Jiang","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.287","article-title":"Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.","volume":"41","author":"Willer","year":"2009","journal-title":"Nat Genet"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/jcp.0b013e3180582412","article-title":"Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population.","volume":"27","author":"Zhang","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01213011-200504000-00002","article-title":"Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis.","volume":"15","author":"Templeman","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pnpbp.2007.08.002","article-title":"Possible association between the 2548A\/G polymorphism of the leptin gene and olanzapine-induced weight gain.","volume":"32","author":"Kang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R29-3-20210128","first-page":"57","article-title":"Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.","volume":"40","author":"Ellingrod","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JCP.0b013e31819359be","article-title":"Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.","volume":"29","author":"Gregoor","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-7893.2008.00074.x","article-title":"Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis.","volume":"2","author":"Pelayo-Teran","year":"2008","journal-title":"Early Interv Psychiatry"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/oby.2009.469","article-title":"Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population.","volume":"18","author":"Liu","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.274","article-title":"Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity.","volume":"41","author":"Thorleifsson","year":"2009","journal-title":"Nat Genet"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ng.301","article-title":"Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations.","volume":"41","author":"Meyre","year":"2009","journal-title":"Nat Genet"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07848","article-title":"Inactivation of the FTO gene protects from obesity.","volume":"458","author":"Fischer","year":"2009","journal-title":"Nature"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/oby.2008.618","article-title":"The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study.","volume":"17","author":"Lappalainen","year":"2009","journal-title":"Obesity"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3945\/ajcn.2009.27652","article-title":"Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene.","volume":"90","author":"Vimaleswaran","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/archinte.168.16.1791","article-title":"Physical activity and the association of common FTO gene variants with body mass index and obesity.","volume":"168","author":"Rampersaud","year":"2008","journal-title":"Arch Intern Med"},{"key":"R42-3-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/oby.2007.637","article-title":"The SH2B gene is associated with serum leptin and body fat in normal female twins.","volume":"15","author":"Jamshidi","year":"2007","journal-title":"Obesity"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/hmg\/ddp041","article-title":"Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden.","volume":"18","author":"Renstrom","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/YPG.0b013e3283328e06","article-title":"Leptin gene 2548G\/A variants predict risperidone-associated weight gain in children and adolescents.","volume":"19","author":"Calarge","year":"2009","journal-title":"Psychiatr Genet"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/aje\/kwi174","article-title":"Genetics of leptin and obesity: a HuGE review.","volume":"162","author":"Paracchini","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2337\/diab.46.11.1898","article-title":"The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity.","volume":"46","author":"Silver","year":"1997","journal-title":"Diabetes"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1210\/jcem.86.9.7842","article-title":"The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability.","volume":"86","author":"Yiannakouris","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-3-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1469-1809.1999.6330227.x","article-title":"Sequence variants in the 5 flanking region of the leptin gene are associated with obesity in women.","volume":"63","author":"Li","year":"1999","journal-title":"Ann Hum Genet"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/hmg\/6.6.869","article-title":"Leptin receptor gene variation and obesity: lack of association in a white British male population.","volume":"6","author":"Gotoda","year":"1997","journal-title":"Hum Mol Genet"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2002-33466","article-title":"A polymorphism in the leptin promoter region (2548 G\/A) influences gene expression and adipose tissue secretion of leptin.","volume":"34","author":"Hoffstedt","year":"2002","journal-title":"Horm Metab Res"},{"key":"R51-3-20210128","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.jcp.0000203196.65710.2b","article-title":"Risperidone-related weight gain: genetic and nongenetic predictors.","volume":"26","author":"Lane","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R52-3-20210128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.mp.4001944","article-title":"Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.","volume":"12","author":"Ruano","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R53-3-20210128","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.mp.4002133","article-title":"Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?","volume":"14","author":"Le Hellard","year":"2009","journal-title":"Mol Psychiatry"},{"key":"R54-3-20210128","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0140-6736(02)08913-4","article-title":"Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.","volume":"359","author":"Reynolds","year":"2002","journal-title":"Lancet"},{"key":"R55-3-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/oby.2008.613","article-title":"Missing heritability and GWAS utility.","volume":"17","author":"Bogardus","year":"2009","journal-title":"Obesity"},{"key":"R56-3-20210128","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201012000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:36:06Z","timestamp":1786041366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201012000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181fae248","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}